Amicus Therapeutics
FOLD
#3550
Rank
โ‚น261.54 B
Marketcap
โ‚น875.30
Share price
-1.14%
Change (1 day)
2.44%
Change (1 year)

Revenue for Amicus Therapeutics (FOLD)

Revenue in 2024 (TTM): โ‚น37.95 Billion

According to Amicus Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚น38.46 Billion. In 2023 the company made a revenue of โ‚น33.24 Billion an increase over the revenue in the year 2022 that were of โ‚น27.24 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Amicus Therapeutics from 2008 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น37.95 B14.16%
2023 โ‚น33.24 B22.03%
2022 โ‚น27.24 B19.81%
2021 โ‚น22.73 B19.18%
2020 โ‚น19.07 B46.82%
2019 โ‚น12.99 B103.69%
2018 โ‚น6.38 B170.57%
2017 โ‚น2.35 B599.87%
2016 โ‚น0.33 B
2015 N/A-100%
2014 โ‚น77.57 M245.91%
2013 โ‚น22.42 M-97.78%
2012 โ‚น1.00 B-11.09%
2011 โ‚น1.13 B2644.44%
2010 โ‚น41.31 M-98.62%
2009 โ‚น2.98 B315.15%
2008 โ‚น0.71 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น816.38 B 2,022.66%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น232.35 B 504.14%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น23.44 B-39.04%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น3.397 T 8,734.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น0.30 B-99.20%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น3.150 T 8,092.57%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark